These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24602794)
1. Antiobesity, antioxidant and cytotoxicity activities of newly synthesized chalcone derivatives and their metal complexes. El Sayed Aly MR; Abd El Razek Fodah HH; Saleh SY Eur J Med Chem; 2014 Apr; 76():517-30. PubMed ID: 24602794 [TBL] [Abstract][Full Text] [Related]
2. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II). Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191 [TBL] [Abstract][Full Text] [Related]
3. Studies on chalcone derivatives: complex formation, thermal behavior, stability constant and antioxidant activity. El-Sayed YS; Gaber M Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():423-31. PubMed ID: 25238180 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents. Zhang HJ; Qian Y; Zhu DD; Yang XG; Zhu HL Eur J Med Chem; 2011 Sep; 46(9):4702-8. PubMed ID: 21816517 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. Vogel S; Barbic M; Jürgenliemk G; Heilmann J Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, spectral characterization, solution equilibria, in vitro antibacterial and cytotoxic activities of Cu(II), Ni(II), Mn(II), Co(II) and Zn(II) complexes with Schiff base derived from 5-bromosalicylaldehyde and 2-aminomethylthiophene. El-Sherif AA; Eldebss TM Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1803-14. PubMed ID: 21705267 [TBL] [Abstract][Full Text] [Related]
8. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications. Mahapatra DK; Bharti SK; Asati V; Singh SK Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237 [TBL] [Abstract][Full Text] [Related]
10. Anti-breast cancer activity of heteroaryl chalcone derivatives. Solomon VR; Lee H Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells. Nagaraju M; Gnana Deepthi E; Ashwini C; Vishnuvardhan MV; Lakshma Nayak V; Chandra R; Ramakrishna S; Gawali BB Bioorg Med Chem Lett; 2012 Jul; 22(13):4314-7. PubMed ID: 22668451 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents. Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives. Na Y; Nam JM Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, dimerization, and biological activity of hexaoxygenated chalcones related to calythropsin and combretastatins. Seguin E; Elomri A; Magiatis P; Skaltsounis AL; Chao LR; Tillequin F Nat Prod Lett; 2002 Jun; 16(3):187-93. PubMed ID: 12049219 [TBL] [Abstract][Full Text] [Related]
16. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships. Cabrera M; Simoens M; Falchi G; Lavaggi ML; Piro OE; Castellano EE; Vidal A; Azqueta A; Monge A; de Ceráin AL; Sagrera G; Seoane G; Cerecetto H; González M Bioorg Med Chem; 2007 May; 15(10):3356-67. PubMed ID: 17383189 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of di-phenyl-tin(IV)-salicyliden-ortho-aminophenols: analysis of in vitro antitumor/antioxidant activities and molecular structures. Beltrán HI; Damian-Zea C; Hernández-Ortega S; Nieto-Camacho A; Ramírez-Apan MT J Inorg Biochem; 2007 Jul; 101(7):1070-85. PubMed ID: 17555822 [TBL] [Abstract][Full Text] [Related]
18. Balanochalcone, a new chalcone from Balanophora laxiflora Hemsl. Quang DN; So TC; Thanh NTP; Hoa LTP; Dien PH; Luong TM; Tung NQ; Long LD; Dai TD; Tien NQ Nat Prod Res; 2018 Apr; 32(7):767-772. PubMed ID: 28778140 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones. Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809 [TBL] [Abstract][Full Text] [Related]
20. Bis-chalcone analogues as potent NO production inhibitors and as cytotoxic agents. Vijaya Bhaskar Reddy M; Shen YC; Ohkoshi E; Bastow KF; Qian K; Lee KH; Wu TS Eur J Med Chem; 2012 Jan; 47(1):97-103. PubMed ID: 22115618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]